Showing results (821-830 of 1,251) with videos related to

Sort By:
Pageof 126
Cancer Treatment and Research Communications|March 27, 2025
Carfilzomib in relapsed/refractory multiple myeloma patients - real world evidence - experiences of the Croatian cooperative group for hematologic diseases (KROHEM)Davor Galusic, Josip Batinic, Ivan Krecak, et al.
Cancer Treatment and Research Communications|April 11, 2025
Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategiesHeidi A Abouzeid, Loay Kassem, Xuemei Liu, et al.
Cancer Treatment and Research Communications|June 12, 2023
Treatment of unresectable stage III NSCLC: Real world cohort study and literature reviewSaartje Verfaillie, Maarten Lambrecht, Patrick Berkovic, et al.
Cancer Treatment and Research Communications|June 10, 2023
Comparison of sequential versus simultaneous integrated boost of volumetric modulated arc therapy in treatment of oropharyngeal carcinomaAvni Kachhwaha, Ramakant Tiwari, Sanjib Gayen, et al.
Cancer Treatment and Research Communications|February 20, 2026
From pixels to prognosis: A QUADAS-2-Guided systematic review and meta-analysis of deep learning segmentation for DLBCL in PET and PET/CTSajad Keshavarz, Elham Saeedzadeh, Hossein Arabi, et al.
Cancer Treatment and Research Communications|February 20, 2026
SLFN5 as a dual-function oncogene and immune regulator: A pan-cancer multi-omics analysis linking prognosis, immune evasion, and therapeutic vulnerabilityFubiao Kang, Ziye Yang, Dong Li, et al.
Cancer Treatment and Research Communications|February 18, 2026
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trialChiara Mattioli, Emanuela Olmetto, Marco Banini, et al.
Cancer Treatment and Research Communications|March 7, 2026
Lenvatinib plus pembrolizumab for advanced or recurrent endometrial cancer: a retrospective multi-institutional survey in the Kinki district of JapanYasushi Mabuchi, Kyoka Takahashi, Takuya Yokoe, et al.
Cancer Treatment and Research Communications|March 4, 2026
Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospectsUsamah Sayed, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Cancer Treatment and Research Communications|February 26, 2026
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyPaolo Bironzo, Alessandro Morabito, Sonia Silipigni, et al.
Pageof 126